You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

CLINICAL TRIALS PROFILE FOR VALTOCO


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for VALTOCO

Trial ID Title Status Sponsor Phase Start Date Summary
NCT05076838 ↗ Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy Recruiting Neurelis, Inc. Phase 1/Phase 2 2021-11-01 This is a Phase 1/2a, open-label, single-dose, PK study of VALTOCO with open-label safety period in pediatric epilepsy subjects age 2 to 5 years.
NCT05273398 ↗ Effects of Diazepam on RNS Detections Not yet recruiting University of Cincinnati Phase 4 2022-03-01 To assess the magnitude and duration of reduction in RNS recorded Detections and Long Episodes following intranasal administration of Valtoco®. All participants will have been implanted and treated with an RNS system for clinical purposes and regularly upload Detection and Long Episode data on a regular basis as part of regular clinical treatment. Participants will come to the clinic and be administered a single dose of Valtoco® via nasal spray. RNS recorded Detections and Long Episodes before and after Valtoco® administration will be compared. This is a pilot study, so all outcomes are exploratory.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for VALTOCO

Condition Name

Condition Name for VALTOCO
Intervention Trials
Epilepsy 1
Epilepsies, Partial 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for VALTOCO
Intervention Trials
Epilepsy 2
Epilepsies, Partial 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for VALTOCO

Trials by Country

Trials by Country for VALTOCO
Location Trials
United States 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for VALTOCO
Location Trials
Virginia 1
New Jersey 1
Georgia 1
Florida 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for VALTOCO

Clinical Trial Phase

Clinical Trial Phase for VALTOCO
Clinical Trial Phase Trials
Phase 4 1
Phase 1/Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for VALTOCO
Clinical Trial Phase Trials
Not yet recruiting 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for VALTOCO

Sponsor Name

Sponsor Name for VALTOCO
Sponsor Trials
Neurelis, Inc. 1
University of Cincinnati 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for VALTOCO
Sponsor Trials
Industry 1
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.